World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
62
Citations
20990
World Ranking
1833
National Ranking
917

Shridar Ganesan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Shridar Ganesan sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 315 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Shridar Ganesan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Shridar Ganesan sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 62 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Shridar Ganesan is affiliated with Rutgers, The State University of New Jersey in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, and Pathology and Forensic Medicine.

Their work covers a range of topics, with a particular focus on:

  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • RNA modifications and cancer
  • Genetic factors in colorectal cancer
  • Epigenetics and DNA Methylation
  • Breast Cancer Treatment Studies
  • DNA Repair Mechanisms

They have frequently published research in several prominent venues, including:

  • Cancer Research
  • JCO Precision Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cureus
  • Clinical Cancer Research

Notable recent papers by Shridar Ganesan include:

  • Understanding and overcoming resistance to PARP inhibitors in cancer therapy, 2021, Nature Reviews Clinical Oncology
  • Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers, 2021, ESMO Open
  • Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity, 2020, JCO Precision Oncology
  • Emerging strategies for treating metastasis, 2021, Nature Cancer
  • Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer, 2021, Frontiers in Oncology

Frequent collaborators in their research include Coral Omene, Gregory Riedlinger, Mridula George, Deborah Toppmeyer, and Hossein Khiabanian.

Best Publications

  • Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing

    Chryssa Kanellopoulou;Stefan A. Muljo;Andrew L. Kung;Shridar Ganesan

  • Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

    Irene Garcia-Higuera;Toshiyasu Taniguchi;Shridar Ganesan;M.Stephen Meyn

  • 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

    Peter Bouwman;Amal Mahmoud Aly;Jose M. Escandell;Mark Pieterse

  • X chromosomal abnormalities in basal-like human breast cancer

    Andrea L. Richardson;Zhigang C. Wang;Arcangela De Nicolo;Arcangela De Nicolo;Xin Lu

  • BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

    Sharon B. Cantor;Daphne W. Bell;Shridar Ganesan;Elizabeth M. Kass

  • Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent

    Angel Cruz-Roa;Angel Cruz-Roa;Hannah Leah Gilmore;Ajay Basavanhally;Michael Feldman

  • The telomerase reverse transcriptase regulates chromatin state and DNA damage responses

    Kenkichi Masutomi;Richard Possemato;Judy M. Y. Wong;Jennifer L. Currier

  • Genetic analysis of BRCA1 function in a defined tumor cell line.

    Ralph Scully;Shridar Ganesan;Katerina Vlasakova;Junjie Chen

  • Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation.

    Kwok Kin Wong;Sandy Chang;Sarah R. Weiler;Shridar Ganesan

  • BRCA1 Supports XIST RNA Concentration on the Inactive X Chromosome

    Shridar Ganesan;Daniel P. Silver;Roger A. Greenberg;Dror Avni

  • Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns

    A. Rose Brannon;Anupama Reddy;Michael Seiler;Alexandra Arreola

  • Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma

    Huiqing Liu;Angela R Brannon;Anupama R Reddy;Gabriela Alexe

  • Location of BRCA1 in Human Breast and Ovarian Cancer Cells

    Scully R;Ganesan S;Brown M;De Caprio Ja

  • BMI1 Is Recruited to DNA Breaks and Contributes to DNA Damage-Induced H2A Ubiquitination and Repair

    Vasudeva Ginjala;Karim Nacerddine;Atul Kulkarni;Jay Oza

  • High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates.

    Gabriela Alexe;Gul S. Dalgin;Daniel Scanfeld;Pablo Tamayo

  • Mutational landscape of the essential autophagy gene BECN1 in human cancers.

    Saurabh V. Laddha;Shridar Ganesan;Chang S. Chan;Eileen White

  • Tumorigenesis in mice carrying a truncating Brca1 mutation

    Thomas Ludwig;Peter Fisher;Shridar Ganesan;Argiris Efstratiadis

  • The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis

    Shilpy Joshi;Denis Tolkunov;Hana Aviv;Abraham A. Hakimi

  • The disappearing Barr body in breast and ovarian cancers

    Gayle Jeannette Pageau;Lisa L. Hall;Shridar Ganesan;David M. Livingston

  • Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage.

    Dror Avni;Hong Yang;Fabio Martelli;Francesco Hofmann

Frequent Co-Authors

Siraj M. Ali
Siraj M. Ali Foundation Medicine
Anant Madabhushi
Anant Madabhushi Emory University
Jeffrey S. Ross
Jeffrey S. Ross Foundation Medicine
Michael Feldman
Michael Feldman University of Pennsylvania
John E. Tomaszewski
John E. Tomaszewski University at Buffalo, State University of New York
Eileen White
Eileen White Rutgers, The State University of New Jersey
Garrett M. Frampton
Garrett M. Frampton Foundation Medicine
Howard L. Kaufman
Howard L. Kaufman Harvard University
Ronny Drapkin
Ronny Drapkin University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA can open doors to a wide range of exciting interdisciplinary career paths. The analytical and research skills gained through molecular biology studies provide a strong foundation for various fields, many of which you can pursue through remote learning.

If you're considering a shift from education to healthcare, you may be interested in transitioning from teacher to speech pathologist. This pathway utilizes communication and science skills, blending your background with new clinical expertise.

Those looking for creative and technical growth may opt for an architecture degree online or explore a graphic design degree online. Both options can complement scientific thinking with design innovation.

Additionally, an online mathematics degree offers strong quantitative skills that are highly valued in research, biotech, and data analysis roles—often overlapping with molecular biology.

Whether you wish to stay in science or venture into related fields, online degrees provide flexible options to expand your expertise and career prospects.

Best Scientists Citing Shridar Ganesan

Trending Scientists

Recently Published Articles